Apollomics Inc (NASDAQ:APLM) has a beta value of 0.77 and has seen 0.41 million shares traded in the recent trading session. The company, currently valued at $8.28M, closed the recent trade at $7.51 per share which meant it lost -$0.1 on the day or -1.31% during that session. The APLM stock price is -872.04% off its 52-week high price of $73.00 and 17.44% above the 52-week low of $6.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 15100.0 shares traded. The 3-month trading volume is 11.75K shares.
The consensus among analysts is that Apollomics Inc (APLM) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Apollomics Inc (NASDAQ:APLM) trade information
Sporting -1.31% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the APLM stock price touched $7.51 or saw a rise of 27.02%. Year-to-date, Apollomics Inc shares have moved -22.97%, while the 5-day performance has seen it change -20.95%. Over the past 30 days, the shares of Apollomics Inc (NASDAQ:APLM) have changed 21.13%. Short interest in the company has seen 2634.0 shares shorted with days to cover at 0.58.
Apollomics Inc (APLM) estimates and forecasts
The company’s shares have lost -43.53% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -98.14% over the past 5 years.
APLM Dividends
Apollomics Inc is expected to release its next earnings report on 2024-Mar-27 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Apollomics Inc (NASDAQ:APLM)’s Major holders
Insiders own 40.29% of the company shares, while shares held by institutions stand at 1.19% with a share float percentage of 1.99%. Investors are also buoyed by the number of investors in a company, with Apollomics Inc having a total of 7.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are ETF Series Solutions-Range Cancer Therapeutics ETF and Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund . As of Nov 30, 2024 , the former fund manager holds about 0.01% shares in the company for having 12.59 shares of worth $94684.0 while later fund manager owns 437.0 shares of worth $3286.0 as of Jan 31, 2025 , which makes it owner of about 0.00% of company’s outstanding stock.
